Detection of Reduced Acetaldehyde Protein Adducts Using a Unique Monoclonal Antibody

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Acetaldehyde (AA), the major product of alcohol metabolism, has been shown to bind to proteins in vivo and form chemical adducts. These AA‐protein adducts have been shown to alter protein structure and function and may result in tissue damage. Recent reports have shown that polyclonal antibodies can be produced that recognize proteins modified in vitro with AA in the presence of sodium cyanoborohydride (NaCNBH3), a strong reducing (R) agent. Antibodies prepared in this way have been shown to recognize proteins in the livers of rats fed alcohol chronically. Because multiple AA‐protein adducts can be recognized by polyclonal antisera, and a variety of adducts may be formed in vitro or in vivo, this study was designed to develop monoclonal antibodies specific for proteins modified by AA. In addition, adducts formed under R conditions are probably chemically different than those formed under nonreducing (NR) conditions, and monoclonal antibodies may provide the specificity required to distinguish these chemical differences. Balb/c mice were immunized with bovine brain tubulin that was modified by treatment with 5 mM AA for 7 days under NR conditions. Sera from immunized animals were tested for antibody activity to the immunogen (protein‐NR) and for cross‐reactivity to protein‐R and unmodified protein. Although the highest serum antibody titers were seen toward the NR adduct, antibodies to the R adduct were also detected. This activity difference was independent of the carrier protein, because NR and R bovine serum albumin, keyhole limpet hemocyanin, and actin also gave similar results when used as the adducted protein. Surprisingly, all the monoclonal antibodies (RT1.1, RT1.2, RT1.3, and RT1.4) produced by hybridomas generated from spleen cells from NR‐tubulin immunized mice recognized the R and not the NR adduct. One of these hybridomas (RT1.1) produces an lgG2b antibody that reacts with all tested proteins that have been modified with AA under chemical R conditions. Because of its monoclonal specificity, this antibody may be useful in probing for the presence of R AA‐protein adducts made both in vitro and in vivo.

Original languageEnglish (US)
Pages (from-to)164-171
Number of pages8
JournalAlcoholism: Clinical and Experimental Research
Volume18
Issue number1
DOIs
StatePublished - Feb 1994

Fingerprint

Acetaldehyde
Monoclonal Antibodies
Antibodies
Proteins
Hybridomas
Alcohols
Reducing Agents
Tubulin
Bovine Serum Albumin
Serum
Metabolism
Liver
Rats
Actins
Immune Sera
Brain
Carrier Proteins
Animals
Spleen
Tissue

Keywords

  • Acetaldehyde
  • Adduct
  • Alcohol
  • ELISA
  • Monoclonal Antibody

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Toxicology
  • Psychiatry and Mental health

Cite this

@article{1309dd6befe140e28097732d7925bc51,
title = "Detection of Reduced Acetaldehyde Protein Adducts Using a Unique Monoclonal Antibody",
abstract = "Acetaldehyde (AA), the major product of alcohol metabolism, has been shown to bind to proteins in vivo and form chemical adducts. These AA‐protein adducts have been shown to alter protein structure and function and may result in tissue damage. Recent reports have shown that polyclonal antibodies can be produced that recognize proteins modified in vitro with AA in the presence of sodium cyanoborohydride (NaCNBH3), a strong reducing (R) agent. Antibodies prepared in this way have been shown to recognize proteins in the livers of rats fed alcohol chronically. Because multiple AA‐protein adducts can be recognized by polyclonal antisera, and a variety of adducts may be formed in vitro or in vivo, this study was designed to develop monoclonal antibodies specific for proteins modified by AA. In addition, adducts formed under R conditions are probably chemically different than those formed under nonreducing (NR) conditions, and monoclonal antibodies may provide the specificity required to distinguish these chemical differences. Balb/c mice were immunized with bovine brain tubulin that was modified by treatment with 5 mM AA for 7 days under NR conditions. Sera from immunized animals were tested for antibody activity to the immunogen (protein‐NR) and for cross‐reactivity to protein‐R and unmodified protein. Although the highest serum antibody titers were seen toward the NR adduct, antibodies to the R adduct were also detected. This activity difference was independent of the carrier protein, because NR and R bovine serum albumin, keyhole limpet hemocyanin, and actin also gave similar results when used as the adducted protein. Surprisingly, all the monoclonal antibodies (RT1.1, RT1.2, RT1.3, and RT1.4) produced by hybridomas generated from spleen cells from NR‐tubulin immunized mice recognized the R and not the NR adduct. One of these hybridomas (RT1.1) produces an lgG2b antibody that reacts with all tested proteins that have been modified with AA under chemical R conditions. Because of its monoclonal specificity, this antibody may be useful in probing for the presence of R AA‐protein adducts made both in vitro and in vivo.",
keywords = "Acetaldehyde, Adduct, Alcohol, ELISA, Monoclonal Antibody",
author = "Klassen, {Lynell Warren} and Tuma, {D. J.} and Sorrell, {Michael Floyd} and McDonald, {Thomas L} and DeVasure, {J. M.} and Thiele, {Geoffrey Milton}",
year = "1994",
month = "2",
doi = "10.1111/j.1530-0277.1994.tb00898.x",
language = "English (US)",
volume = "18",
pages = "164--171",
journal = "Alcoholism: Clinical and Experimental Research",
issn = "0145-6008",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Detection of Reduced Acetaldehyde Protein Adducts Using a Unique Monoclonal Antibody

AU - Klassen, Lynell Warren

AU - Tuma, D. J.

AU - Sorrell, Michael Floyd

AU - McDonald, Thomas L

AU - DeVasure, J. M.

AU - Thiele, Geoffrey Milton

PY - 1994/2

Y1 - 1994/2

N2 - Acetaldehyde (AA), the major product of alcohol metabolism, has been shown to bind to proteins in vivo and form chemical adducts. These AA‐protein adducts have been shown to alter protein structure and function and may result in tissue damage. Recent reports have shown that polyclonal antibodies can be produced that recognize proteins modified in vitro with AA in the presence of sodium cyanoborohydride (NaCNBH3), a strong reducing (R) agent. Antibodies prepared in this way have been shown to recognize proteins in the livers of rats fed alcohol chronically. Because multiple AA‐protein adducts can be recognized by polyclonal antisera, and a variety of adducts may be formed in vitro or in vivo, this study was designed to develop monoclonal antibodies specific for proteins modified by AA. In addition, adducts formed under R conditions are probably chemically different than those formed under nonreducing (NR) conditions, and monoclonal antibodies may provide the specificity required to distinguish these chemical differences. Balb/c mice were immunized with bovine brain tubulin that was modified by treatment with 5 mM AA for 7 days under NR conditions. Sera from immunized animals were tested for antibody activity to the immunogen (protein‐NR) and for cross‐reactivity to protein‐R and unmodified protein. Although the highest serum antibody titers were seen toward the NR adduct, antibodies to the R adduct were also detected. This activity difference was independent of the carrier protein, because NR and R bovine serum albumin, keyhole limpet hemocyanin, and actin also gave similar results when used as the adducted protein. Surprisingly, all the monoclonal antibodies (RT1.1, RT1.2, RT1.3, and RT1.4) produced by hybridomas generated from spleen cells from NR‐tubulin immunized mice recognized the R and not the NR adduct. One of these hybridomas (RT1.1) produces an lgG2b antibody that reacts with all tested proteins that have been modified with AA under chemical R conditions. Because of its monoclonal specificity, this antibody may be useful in probing for the presence of R AA‐protein adducts made both in vitro and in vivo.

AB - Acetaldehyde (AA), the major product of alcohol metabolism, has been shown to bind to proteins in vivo and form chemical adducts. These AA‐protein adducts have been shown to alter protein structure and function and may result in tissue damage. Recent reports have shown that polyclonal antibodies can be produced that recognize proteins modified in vitro with AA in the presence of sodium cyanoborohydride (NaCNBH3), a strong reducing (R) agent. Antibodies prepared in this way have been shown to recognize proteins in the livers of rats fed alcohol chronically. Because multiple AA‐protein adducts can be recognized by polyclonal antisera, and a variety of adducts may be formed in vitro or in vivo, this study was designed to develop monoclonal antibodies specific for proteins modified by AA. In addition, adducts formed under R conditions are probably chemically different than those formed under nonreducing (NR) conditions, and monoclonal antibodies may provide the specificity required to distinguish these chemical differences. Balb/c mice were immunized with bovine brain tubulin that was modified by treatment with 5 mM AA for 7 days under NR conditions. Sera from immunized animals were tested for antibody activity to the immunogen (protein‐NR) and for cross‐reactivity to protein‐R and unmodified protein. Although the highest serum antibody titers were seen toward the NR adduct, antibodies to the R adduct were also detected. This activity difference was independent of the carrier protein, because NR and R bovine serum albumin, keyhole limpet hemocyanin, and actin also gave similar results when used as the adducted protein. Surprisingly, all the monoclonal antibodies (RT1.1, RT1.2, RT1.3, and RT1.4) produced by hybridomas generated from spleen cells from NR‐tubulin immunized mice recognized the R and not the NR adduct. One of these hybridomas (RT1.1) produces an lgG2b antibody that reacts with all tested proteins that have been modified with AA under chemical R conditions. Because of its monoclonal specificity, this antibody may be useful in probing for the presence of R AA‐protein adducts made both in vitro and in vivo.

KW - Acetaldehyde

KW - Adduct

KW - Alcohol

KW - ELISA

KW - Monoclonal Antibody

UR - http://www.scopus.com/inward/record.url?scp=0028198084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028198084&partnerID=8YFLogxK

U2 - 10.1111/j.1530-0277.1994.tb00898.x

DO - 10.1111/j.1530-0277.1994.tb00898.x

M3 - Article

C2 - 8198215

AN - SCOPUS:0028198084

VL - 18

SP - 164

EP - 171

JO - Alcoholism: Clinical and Experimental Research

JF - Alcoholism: Clinical and Experimental Research

SN - 0145-6008

IS - 1

ER -